Classification of the Crystallization Behavior of Amorphous Active Pharmaceutical Ingredients in Aqueous Environments
- 23 November 2013
- journal article
- research article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 31 (4) , 969-982
Abstract
To classify the crystallization behavior of amorphous active pharmaceutical ingredients (API) exposed to aqueous environments.Keywords
This publication has 38 references indexed in Scilit:
- Solubility Advantage of Amorphous Pharmaceuticals, Part 3: Is Maximum Solubility Advantage Experimentally Attainable and Sustainable?Journal of Pharmaceutical Sciences, 2011
- Solubility Advantage of Amorphous Pharmaceuticals: II. Application of Quantitative Thermodynamic Relationships for Prediction of Solubility Enhancement in Structurally Diverse Insoluble PharmaceuticalsPharmaceutical Research, 2010
- Solubility advantage of amorphous pharmaceuticals: I. A thermodynamic analysisJournal of Pharmaceutical Sciences, 2010
- Top-down production of drug nanocrystals: Nanosuspension stabilization, miniaturization and transformation into solid productsInternational Journal of Pharmaceutics, 2008
- Prodrug strategies to overcome poor water solubilityAdvanced Drug Delivery Reviews, 2007
- Cyclodextrins as pharmaceutical solubilizersAdvanced Drug Delivery Reviews, 2007
- Solubilization by cosolventsInternational Journal of Pharmaceutics, 2002
- Improving drug solubility for oral delivery using solid dispersionsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2000
- Drug-like properties and the causes of poor solubility and poor permeabilityJournal of Pharmacological and Toxicological Methods, 2000
- What is the True Solubility Advantage for Amorphous Pharmaceuticals?Pharmaceutical Research, 2000